JP Morgan Chase
COLL icon

JP Morgan Chase’s Collegium Pharmaceutical COLL Stock Holding History

JP Morgan Chase’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-90,000
Closed -$1.33M – 5710
2018
Q3 		$1.33M Buy
+90,000
New +$1.6M ﹤0.01% 3730

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

JP Morgan Chase's COLL Position: Q2 2026 in Review

JP Morgan Chase reduced its Collegium Pharmaceutical (COLL) stake by 36% in Q2 2026, selling an estimated $1.35M and leaving 71,063 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #4018.

JP Morgan Chase first reported a position in COLL in Q4 2015 and has held it in 40 quarters since. The position peaked at $10.7M in Q3 2024. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • JP Morgan Chase held 71,063 shares of Collegium Pharmaceutical worth $2.56M as of Q2 2026.
  • JP Morgan Chase sold 39,639 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.35M.
  • Collegium Pharmaceutical made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4018 holding.
  • JP Morgan Chase first reported a position in Collegium Pharmaceutical in Q4 2015 and has held it in 40 quarters since.
  • JP Morgan Chase's Collegium Pharmaceutical position peaked at $10.7M in Q3 2024.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.